ArticleScientific reports2026
MRI neuroimaging-based Alzheimer's disease stage classification using deep neural network with convolutional block attention module and GAN-style noise injection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Millions of individuals worldwide suffer from Alzheimer's disease (AD), a chronic, incurable neurological disorder. For the longevity of people, a computer-aided system can contribute to the maximum possible extent. Recently, Deep-learning algorithms have shown better results than machine learning techniques. Researchers have applied CNN models on MRI datasets in various recent studies and have obtained promising results for the early detection of AD. This study proposes a Neuro_CBAM-ADNet diagnostic model for early prediction of the four stages of AD, using MRI digital images. The results show that the proposed model achieved mean accuracy of 98.28%±0.31, which also outperforms the previous related works. The proposed model can identify AD without human intervention and also at an economical cost with high accuracy. The optimistic findings of deep learning models in the early diagnosis of illnesses like AD show that deep learning plays a crucial role in combating these neurological diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.